CLDN18 and signet ring cell carcinoma: found that the frequency of CLDN18-ARHGAP fusion is 18.25% in signet-ring cell carcinoma, and the CLDN18-ARHGAP26/6 fusion is associated with signet-ring cell content, age at diagnosis, female/male ratio, and TNM stage.